Frontiers in Immunology

ISSNs: 1664-3224

Additional searchable ISSN (electronic): 1664-3224

Frontiers Media S.A.

Scopus rating (2023): CiteScore 9.8 SJR 1.868 SNIP 1.193

Indexed in DOAJ

Journal

Titles	Frontiers in Immunology Frontiers in immunology
Additional searchable titles	Frontiers in immunology, Front Immunol
ISSNs	1664-3224
Additional searchable ISSN (electronic)	1664-3224
Publisher	Frontiers Media S.A.
ZDB-ID	2606827-8

Keywords

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Library keywords

610 Medicine and health

A future of AI-driven personalized care for people with multiple sclerosis

Praet, J., Anderhalten, L., Comi, G., Horakova, D., Ziemssen, T., Vermersch, P., Lukas, C., & 11 othersvan Leemput, K., Steppe, M., Aguilera, C., Kadas, E. M., Bertrand, A., van Rampelbergh, J., de Boer, E., Zingler, V., Smeets, D., Ribbens, A. & Paul, F., 19 Aug 2024, In: Frontiers in immunology. 15 (2024), 10 p., 1446748.

Research output: Contribution to journal › Research article › Contributed › peer-review

Building digital patient pathways for the management and treatment of multiple sclerosis

Wenk, J., Voigt, I., Inojosa, H., Schlieter, H. & Ziemssen, T., 15 Feb 2024, In: Frontiers in immunology. 15, 1356436.

Research output: Contribution to journal › Review article › Contributed › peer-review

Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis

Höpner, L., Proschmann, U., Inojosa, H., Ziemssen, T. & Akgün, K., 2024, In: Frontiers in immunology. 15, 1404316.

Research output: Contribution to journal › Research article › Contributed › peer-review

Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation

Lim, J. H., Neuwirth, A., Chung, K. J., Grossklaus, S., Soehnlein, O., Hajishengallis, G. & Chavakis, T., 2024, In: Frontiers in immunology. 15, 1354074.

Research output: Contribution to journal › Research article › Contributed › peer-review

Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma

Rupp, L., Dietsche, I., Kießler, M., Sommer, U., Muckenhuber, A., Steiger, K., van Eijck, C. W. F., & 8 othersRichter, L., Istvanffy, R., Jäger, C., Friess, H., van Eijck, C. H. J., Demir, I. E., Reyes, C. M. & Schmitz, M., 2024, In: Frontiers in immunology. 15, 1378190.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (85)

Research Portal of the TU Dresden

Frontiers in Immunology

Keywords

ASJC Scopus subject areas

Library keywords

Related content

A future of AI-driven personalized care for people with multiple sclerosis

Building digital patient pathways for the management and treatment of multiple sclerosis

Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis

Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation

Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma